We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s healthcare costs regulator is recommending further research on three new tests that speed up the identification of bacteria and fungi in people with suspected bloodstream infections. Read More
Dan O’Leary, president of Ombu Enterprises, explained the requirements for handling nonconforming products during an FDAnews webinar last month. The following is adapted from that event.Read More